The role of complement in the acquired immune response
- 1 May 2000
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 100 (1), 4-12
- https://doi.org/10.1046/j.1365-2567.2000.00009.x
Abstract
Studies over the past three decades have clearly established a central role for complement in the promotion of a humoral immune response. The primary function of complement, in this regard, is to opsonize antigen or immune complexes for uptake by complement receptor type 2 (CR2, CD21) expressed on B cells, follicular dendritic cells (FDC) and some T cells. A variety of mechanisms appear to be involved in complement-mediated promotion of the humoral response. These include: enhancement of antigen (Ag) uptake and processing by both Ag-specific and non-specific B cells for presentation to specific T cells; the activation of a CD21/CD19 complex-mediated signalling pathway in B cells, which provides a stimulus synergistic to that induced by antigen interaction with the B-cell receptor (BCR); and promotion of the interaction between B cells and FDC, where C3d-bearing immune complexes participate in intercellular bridging. Finally, current studies suggest that CR2 may also play a role in the determination of B-cell tolerance towards self-antigens and thereby hold the key to the previously observed correlation between deficiencies of the early complement components and autoimmune disease.Keywords
This publication has 110 references indexed in Scilit:
- Complement deficiency and autoimmunityCurrent Opinion in Pediatrics, 1998
- The requirement of localized, CR2‐mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cellsImmunology, 1998
- Immunization with immune complex alters the repertoire of antigen-reactive B cells in the germinal centersEuropean Journal of Immunology, 1997
- Complement C3b fragment covalently linked to tetanus toxin increases lysosomal sodium dodecyl sulfate-stable HLA-DR dimer productionEuropean Journal of Immunology, 1997
- Complement receptor expression and activation of the complement cascade on B lymphocytes from patients with systemic lupus erythematosus (SLE)Clinical and Experimental Immunology, 1995
- Binding sites of the Epstein-Barr virus and C3d receptor (CR2, CD21) for its three intracellular ligands, the p53 anti-oncoprotein, the p68 calcium binding protein and the nuclear p120 ribonucleoproteinMolecular Immunology, 1995
- Covalent binding of C3b to monoclonal antibodies selectively up‐regulates heavy chain epitope recognition by T cellsEuropean Journal of Immunology, 1994
- CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoireImmunology Today, 1989
- Appearance of acceptor-bound C3b on HLA-DR positive macrophages and on stimulated U937 cells; Inhibition of Fcγ-receptors by the covalently fixed C3 fragmentsMolecular Immunology, 1988
- Immune Response of a Patient with Deficiency of the Fourth Component of Complement and Systemic Lupus ErythematosusThe New England Journal of Medicine, 1979